GLP-1 Agonists

Survodutide

Catalog #: SUR

Survodutide is a glucagon-biased dual GLP-1/glucagon receptor agonist optimized for hepatic metabolism research. A leading research compound for MASH/NAFLD and liver fat reduction studies.

Catalog Number SUR
Targets GLP-1R + Glucagon Receptor (glucagon-biased)
Modification Fatty acid acylation
Form Lyophilized powder

Available SKUs

Model Specification MOQ
SUR10 10mg / 10ml 1 vial
Ships within 5-7 business days
Certificate of Analysis included
Quality guaranteed

Product Overview

Survodutide is a glucagon-biased dual GLP-1/glucagon receptor agonist optimized for hepatic metabolism research. A leading research compound for MASH/NAFLD and liver fat reduction studies.

Research Applications

  • Glucagon-biased dual GLP-1/glucagon receptor agonist
  • Optimized for hepatic fat metabolism research
  • Drives hepatic β-oxidation via CPT1a upregulation
  • Research focus on MASH/NAFLD paradigms
  • Acylated for extended research duration

Key Features

  • ≥99% purity confirmed by RP-HPLC and ESI-MS
  • For laboratory research use only

Technical Support

Our team of product experts is available to assist with your research needs.

Contact Support

OEM Services

Need modifications or larger quantities? Request a custom synthesis quote.

Request Custom
Catalog Number SUR
Targets GLP-1R + Glucagon Receptor (glucagon-biased)
Modification Fatty acid acylation
Form Lyophilized powder
Purity ≥99% (RP-HPLC)
Storage -20°C, desiccated

Related Products

Need OEM or a Custom Configuration?

We support practical, production-ready customization for peptides, sequences, and modifications. Share your synthesizer type, dimensions, modifications preference, and packaging needs—our team will confirm feasibility and lead time.

Request Custom Synthesis Contact Us